If there is a deal forthwith, then those details are currently being negotiated. Ebola was not on IBIO’s radar, NOR ANY OF THE MAJOR DRUG COMPANIES BECAUSE 1. Previously, it was a relatively rare disease that was thought to affect only remote pockets of Africa. 2. There were no FDA approved Ebola vaccines for IBIO to work with. Therefore there was no feasible stream of income to justify doing so. Until Now. Remember, we are literally talking in terms of weeks from the point that the first case of Ebola appeared in America, to the Federal Government stating it wants 50M doses on hand, to a rush of vaccine producers being called upon to present plans for production on a major scale. This is a crisis where the day to day goings on are fluid for everyone involved. The major takeaway from all of this is that the Feds are so desperate to get a vaccine in the pipeline in massive quantities, that it is almost a given that any company with technology to offer the cause, will get a shot to prove itself.
News 
Market Data 
Discover 
